The global market for GLP-1 receptor agonists shows a surge in demand due to their effectiveness in managing type 2 diabetes. Several biotechnological companies have secured FDA approval to produce these life-changing medications. {Novo Nordisk|Ascensia Pharmais a leading producer of GLP-1 receptor agonists, with highly regarded products like W